ArticleMolecular biology reports2026
Hypoxia-induced GP73 promotes the Warburg effect in hepatocellular carcinoma via HIF-1α.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundTransarterial chemoembolization (TACE)-induced hypoxia is a key driver of hepatocellular carcinoma (HCC) progression. This study investigated whether Golgi protein 73 (GP73) drives the Warburg effect and epithelial-mesenchymal transition (EMT) via hypoxia-inducible factor-1α (HIF-1α) under hypoxia, thereby promoting HCC malignancy.
methodsHepG2 cells were exposed to hypoxia (1% O₂). Lentivirus-mediated GP73 overexpression (LV-GP73) and siRNA-mediated HIF-1α knockdown (si-HIF-1α) were established. Four groups were compared: H + LV-NC (negative control), H + LV-GP73, H + LV-GP73 + si-NC, and H + LV-GP73 + si-HIF-1α. Cell proliferation, apoptosis, migration, and invasion were assessed by colony formation, flow cytometry, and Transwell assays. Glycolysis and mitochondrial respiration were evaluated by biochemical kits and Seahorse XFe24 Analyzer. Protein levels were detected by Western blotting. Clinical validation was performed in peripheral blood mononuclear cells (PBMCs) from 169 HCC patients who underwent TACE.
resultsGP73 overexpression significantly enhanced colony formation, migration, invasion, glucose consumption, lactate production, LDH activity, ATP levels, and extracellular acidification rate, while decreasing apoptosis (P < 0.05). It also showed a decreasing trend in oxygen consumption rate, indicating Warburg effect activation. It also upregulated HIF-1α, glycolytic enzymes (HK2, SLC2A1, LDHA, PGK1), and Vimentin, but downregulated E-cadherin (P < 0.05). Notably, HIF-1α knockdown reversed all these pro-tumorigenic phenotypes, metabolic reprogramming, and molecular changes. Clinical validation further confirmed that PBMCs from TACE-resistant patients exhibited significantly elevated GP73, HIF-1α, and HK2 expression at both mRNA and protein levels (all P < 0.001), consistent with the in vitro findings.
conclusionsUnder hypoxia, GP73 promotes the Warburg effect and EMT through HIF-1α stabilization, facilitating HCC progression. The GP73-HIF-1α axis is a critical mediator of TACE resistance and a potential therapeutic target. PBMC-based detection of this pathway may serve as a non-invasive strategy for monitoring TACE resistance risk.
Indexed as
Identifiers
42911454What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.